Pathogenesis of retinopathy of prematurity

被引:91
作者
Smith, LEH [1 ]
机构
[1] Harvard Univ, Sch Med, Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA
关键词
insulin-like growth factor-1; retinopathy of prematurity; vascular endothelial growth factor;
D O I
10.1080/08035250260095771
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Retinopathy of prematurity (ROP) is a blinding disease, initiated by delayed retinal vascular growth after premature birth. There are both oxygen-regulated and non-oxygen-regulated factors, which contribute to both normal vascular development and retinal neovascularization. One important oxygen-regulated factor, critical to both phases of ROP, is vascular endothelial growth factor (VEGF). A critical non oxygen-regulated growth factor is insulin-like growth factor (IGF-1). In knockout mice, lack of IGF-1 prevents normal retinal vascular growth, despite the presence of VEGF, important to vessel development. In vitro, low IGF-1 prevents vascular endothelial growth factor-induced activation of Akt, a kinase critical for vascular endothelial cell survival. Premature infants who develop ROP have lower levels of serum IGF-1 than age-matched infants without disease. Conclusion: IGF-1 is critical to normal vascular development. Low IGF-1 predicts ROP and restoration of IGF-1 to normal levels may prevent ROP.
引用
收藏
页码:26 / 28
页数:3
相关论文
共 26 条
[1]   Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate [J].
Adamis, AP ;
Shima, DT ;
Tolentino, MJ ;
Gragoudas, ES ;
Ferrara, N ;
Folkman, J ;
DAmore, PA ;
Miller, JW .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (01) :66-71
[2]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[3]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[4]   VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY [J].
ALON, T ;
HEMO, I ;
ITIN, A ;
PEER, J ;
STONE, J ;
KESHET, E .
NATURE MEDICINE, 1995, 1 (10) :1024-1028
[5]   OXYGEN AND GROWTH AND DEVELOPMENT OF RETINAL VESSELS - IN VIVO AND IN VITRO STUDIES - 20 FRANCIS I PROCTOR LECTURE [J].
ASHTON, N ;
PATH, FC .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1966, 62 (03) :412-&
[6]   Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy [J].
Donahue, ML ;
Phelps, DL ;
Watkins, RH ;
LoMonaco, MB ;
Horowitz, S .
CURRENT EYE RESEARCH, 1996, 15 (02) :175-184
[7]  
Flynn J T, 1983, Trans Am Ophthalmol Soc, V81, P549
[8]   Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells:: Direct correlation with clinical retinopathy of prematurity [J].
Hellstrom, A ;
Perruzzi, C ;
Ju, MH ;
Engström, E ;
Hård, AL ;
Liu, JL ;
Albertsson-Wikland, K ;
Carlsson, B ;
Niklasson, A ;
Sjödell, L ;
LeRoith, D ;
Senger, DR ;
Smith, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5804-5808
[9]   INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-INDUCED ANGIOGENESIS SUPPRESSES TUMOR-GROWTH INVIVO [J].
KIM, KJ ;
LI, B ;
WINER, J ;
ARMANINI, M ;
GILLETT, N ;
PHILLIPS, HS ;
FERRARA, N .
NATURE, 1993, 362 (6423) :841-844
[10]  
KINSEY VE, 1977, PEDIATRICS, V60, P655